Why does insulin cost eight times more in America than Canada?
Follow the money from Big Pharma to Republican Senators keeping drug prices high with their filibuster.
Prices for insulin in America doubled between 2012 and 2016. Democrats in the House of Representatives voted Thursday to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare. The Affordable Insulin Now Act caps insulin prices at either $35 a month or 25% of an insurance plan's negotiated price — whichever is lower. Republican Senators have threatened to use the filibuster to keep insulin prices high.
"No one should have to choose between taking their medication as prescribed and putting food on the table or a roof over their head" - NPR. Make it easier to see how voting impacts the price of insulin with this map which shows:
- The number of diabetics in a county
- Senators for that area who are supposed to represent them and not Big Pharma
- How to contact your Senator to tell them to vote to lower insulin prices
- What is in the Affordable Insulin Act Now
- How to register to vote and learn about the latest Voter ID laws
American diabetics struggle with high insulin prices
Vote to lower the price of insulin
“Senate Republicans are working hand in hand with their Big Pharma allies to oppose lowering the costs of medicine like insulin — all so that the GOP’s corporate backers can continue making record profits at hard working Americans’ expense. While Democrats are fighting to lower the costs of healthcare, Republicans are looking out for the rich, the powerful and big corporations who profit by making Americans pay higher prices — and in 2022 voters will hold every GOP Senate candidate accountable.” - DSCC
"This is a kitchen-table issue," said House Speaker Nancy Pelosi, D-Calif. "One in four Americans is forced to skip or ration doses of insulin and that's life-threatening," she said, noting the legislation "paves the way" for further action on negotiating lower drug prices beyond insulin. - NPR
Make a compelling case with maps, the facts and a direct call to action
Make a direct connection between high insulin prices, voting and pharma donations to Republicans to block insulin price caps. This dashboard designed with ArcGIS Online with CDC data by DemLabs in a few hours makes the case clearly and an interactive manner.
- Click on a county and immediately see the number of people suffering from diabetes and affected by high insulin prices.
- Click forward to see the Senators who are supposed to represent that area and how to contact them.
- Click on the links in the side panel to understand why the price of insulin is eight times more in America than Canada.
- What is in the Democratic "Affordable Insulin Now Act"?
- Who are the top 20 Republicans owned by Big Pharma?
- Register to vote and learn about Voter ID laws with Rock The Vote
Compare insulin prices in America, Canada and Mexico
34 million American diabetics
"Rising insulin spending poses a potentially major access challenge for the over 34 million Americans with diabetes. Importantly, our results apply only to people with employer sponsored health insurance. Further, the HCCI data is a subsample of this population; based on the best information available to us, we believe that the racial and ethnic distribution of the population in HCCI's data is similar to the national employer-sponsored insurance population. Nationally, however, Black and Hispanic populations are under-represented in employer-sponsored insurance, and as such insulin use and spending (and related costs of diabetes care and complications) among these individuals is likely under-represented in our findings. This consideration is especially important given that diabetes disproportionately affects Black, Hispanic, and American Indian/Alaska Native populations and that these populations receive relatively worse quality of diabetes care."
TakeAway: Make it easier for people to see how voting can improve their lives with maps and direct calls to action.
Deepak
DemLabs
DISCLAIMER: ALTHOUGH THE DATA FOUND IN THIS BLOG AND INFOGRAPHIC HAS BEEN PRODUCED AND PROCESSED FROM SOURCES BELIEVED TO BE RELIABLE, NO WARRANTY EXPRESSED OR IMPLIED CAN BE MADE REGARDING THE ACCURACY, COMPLETENESS, LEGALITY OR RELIABILITY OF ANY SUCH INFORMATION. THIS DISCLAIMER APPLIES TO ANY USES OF THE INFORMATION WHETHER ISOLATED OR AGGREGATE USES THEREOF.
